BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22213733)

  • 1. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.
    Steele R; Hudson M; Lo E; Baron M;
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):519-24. PubMed ID: 22213733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung disease in systemic sclerosis: a simple staging system.
    Goh NS; Desai SR; Veeraraghavan S; Hansell DM; Copley SJ; Maher TM; Corte TJ; Sander CR; Ratoff J; Devaraj A; Bozovic G; Denton CP; Black CM; du Bois RM; Wells AU
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1248-54. PubMed ID: 18369202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
    Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
    Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
    Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).
    Sieiro Santos C; Antolín SC; Lorenzo JC; Garay CL; Morales CM; de Miguel EB; Guerrero MR; Herránz LS; Álvarez ED
    Semin Arthritis Rheum; 2024 Apr; 65():152366. PubMed ID: 38290372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease.
    Nawata T; Shirai Y; Suzuki M; Kuwana M
    Rheumatology (Oxford); 2021 Jan; 60(1):250-255. PubMed ID: 32699895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.
    Tiev KP; Coste J; Ziani M; Aubourg F; Cabane J; Dinh-Xuan AT
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):32-8. PubMed ID: 19960786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis.
    Pinal-Fernandez I; Pineda-Sanchez V; Pallisa-Nuñez E; Simeon-Aznar CP; Selva-O'Callaghan A; Fonollosa-Pla V; Vilardell-Tarres M
    Clin Rheumatol; 2016 Sep; 35(9):2339-45. PubMed ID: 27107755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis.
    Foeldvari I; Klotsche J; Hinrichs B; Helmus N; Kasapcopur O; Adrovic A; Sztajnbok F; Terreri MT; Anton J; Smith V; Katsicas M; Kostik M; Vasquez-Canizares N; Avcin T; Feldman B; Janarthanan M; Santos MJ; Sawhney S; Schonenberg-Meinema D; Sifuentes-Giraldo WA; Alexeeva E; Appenzeller S; Battagliotti C; Berntson L; Bica B; Costa-Reis P; Eleftheriou D; Kallinich T; Lehman T; Marrani E; Minden K; Nielsen S; Nuruzzaman F; Patwardhan A; Khubchandani R; Stanevicha V; Uziel Y; Torok KS
    Arthritis Care Res (Hoboken); 2022 Mar; 74(3):364-370. PubMed ID: 33141441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
    Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
    J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study.
    Frauenfelder T; Winklehner A; Nguyen TD; Dobrota R; Baumueller S; Maurer B; Distler O
    Ann Rheum Dis; 2014 Dec; 73(12):2069-73. PubMed ID: 25269829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.
    Wu W; Jordan S; Becker MO; Dobrota R; Maurer B; Fretheim H; Ye S; Siegert E; Allanore Y; Hoffmann-Vold AM; Distler O
    Ann Rheum Dis; 2018 Sep; 77(9):1326-1332. PubMed ID: 29875097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression.
    Guler SA; Winstone TA; Murphy D; Hague C; Soon J; Sulaiman N; Li KH; Dunne J; Wilcox PG; Ryerson CJ
    Ann Am Thorac Soc; 2018 Dec; 15(12):1427-1433. PubMed ID: 30188737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.